NCT02959333

Human Amniotic Epithelial Cells for Treatment of Bronchial Fistula

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: The Second Affiliated Hospital of Fujian Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Bronchial fistula (BF), an abnormal passage or communication between a bronchus and another part of the body, may develop when there are penetrating wounds of the thorax and after lung surgery. Without effective therapy, treatment of BF is a challenge, with a high rate of mortality and teratogenicity. The investigators will conduct endoscopic injection of human amniotic epithelial cells to fistula, observe the recovery of bronchial fistula and systemic reactions, to investigate the application of human amniotic epithelial cells in the treatment of bronchial fistula.

Conditions

• Bronchial Fistula

Interventions

Type	Name	Description
BIOLOGICAL	hAEC	hAEC: human amniotic epithelial cells

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-10-01
• Completion: 2017-12-01
• First posted: 2016-11-09
• Last updated: 2016-11-09

Locations

1 site across 1 country: China